Search for author "A. Michael Lincoff"
5 Results
- You have accessRestricted accessAntithrombotic Effect of Tissue Factor Inhibition by Inactivated Factor VIIaAn Ex Vivo Human StudyEli I. Lev, Jonathan D. Marmur, Milan Zdravkovic, Julio I. Osende, Jonathan Robbins, Jenny A. Delfin, Merwin Richard, Elisabeth Erhardtsen, Mikael S. Thomsen, A. Michael Lincoff and Juan J. BadimonArteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1036-1041, originally published April 25, 2002https://doi.org/10.1161/01.ATV.0000019732.25208.B8
- Table 1.You have accessAntithrombotic Effect of Tissue Factor Inhibition by Inactivated Factor VIIaEli I. Lev, Jonathan D. Marmur, Milan Zdravkovic, Julio I. Osende, Jonathan Robbins, Jenny A. Delfin, Merwin Richard, Elisabeth Erhardtsen, Mikael S. Thomsen, A. Michael Lincoff, Juan J. BadimonArteriosclerosis, Thrombosis, and Vascular Biology June 2002, 22 (6) 1036-1041; DOI: https://doi.org/10.1161/01.ATV.0000019732.25208.B8
- You have accessAntithrombotic Effect of Tissue Factor Inhibition by Inactivated Factor VIIaEli I. Lev, Jonathan D. Marmur, Milan Zdravkovic, Julio I. Osende, Jonathan Robbins, Jenny A. Delfin, Merwin Richard, Elisabeth Erhardtsen, Mikael S. Thomsen, A. Michael Lincoff, Juan J. BadimonArteriosclerosis, Thrombosis, and Vascular Biology June 2002, 22 (6) 1036-1041; DOI: https://doi.org/10.1161/01.ATV.0000019732.25208.B8Figure 1. Total thrombus formation in the 3 treatment groups at baseline (black bars) and a...Show MoreFigure 1. Total thrombus formation in the 3 treatment groups at baseline (black bars) and after drug administration (white bars). Group 1 (n=9) received 400 μg/kg FFR-rFVIIa, group 2 (n=7) received 200 μg/kg FFR-rFVIIa, and group 3 (n=8) received 50 μg/kg FFR-rFVIIa. Results are presented for the 3 types of flow chambers (tunica media without TF coverage, 0.1-mm diameter; tunica media with TF, 0.2-mm diameter; and tunica media with TF, 0.1-mm diameter). Total thrombus results are expressed as mean±SEM (in micrometers squared). *P<0.02, †P<0.01, and ‡P<0.03 for baseline vs after drug administration.Show Less
- You have accessAntithrombotic Effect of Tissue Factor Inhibition by Inactivated Factor VIIaEli I. Lev, Jonathan D. Marmur, Milan Zdravkovic, Julio I. Osende, Jonathan Robbins, Jenny A. Delfin, Merwin Richard, Elisabeth Erhardtsen, Mikael S. Thomsen, A. Michael Lincoff, Juan J. BadimonArteriosclerosis, Thrombosis, and Vascular Biology June 2002, 22 (6) 1036-1041; DOI: https://doi.org/10.1161/01.ATV.0000019732.25208.B8Figure 2. Representative photomicrographs of porcine media exposed to flowing blood from a...Show MoreFigure 2. Representative photomicrographs of porcine media exposed to flowing blood from a group 1 patient. Micrograph A was taken at baseline (after heparin bolus); micrograph B was taken after FFR-rFVIIa+heparin administration. Sections were stained with combined Masson’s trichrome-elastin (CME) to demonstrate total thrombus deposition. Original magnification ×100.Show Less
- Table 2.You have accessAntithrombotic Effect of Tissue Factor Inhibition by Inactivated Factor VIIaEli I. Lev, Jonathan D. Marmur, Milan Zdravkovic, Julio I. Osende, Jonathan Robbins, Jenny A. Delfin, Merwin Richard, Elisabeth Erhardtsen, Mikael S. Thomsen, A. Michael Lincoff, Juan J. BadimonArteriosclerosis, Thrombosis, and Vascular Biology June 2002, 22 (6) 1036-1041; DOI: https://doi.org/10.1161/01.ATV.0000019732.25208.B8